Skip to content
value.today

Jet Health, Inc.

Total raised
$38 M
7 rounds on record
Latest round
$2 M
Feb 2022
First round on record
Apr 2016
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Jet Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$2 MNo. 7$2 to $10 million

Jet Health, Inc.: Raise no. 7, Feb 2022

Investors in this round

9 investors had bought by the notice of Jun 27, 2022: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series E-1 Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James D. Glynn · Director, Executive Officer · Mr. Glynn is the Chairman of the Board of Directors.
  • James M. Douthitt · Executive Officer · Mr. Douthitt is the Chief Financial Officer and Secretary of the Issuer.
  • Stacie J. Bratcher · Executive Officer · Ms. Bratcher is the President and Chief Executive Officer of the Issuer.
  • David J. Tamburri · Director
  • Jerome John Lyden · Director
  • Liston J. Thomas · Director
  • Stephen J. Griggs · Director
  • Thomas J. Flynn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacie Bratcher, Chief Executive Officer of the Issuer. Newest notice filed Jun 27, 2022 (1 amendment). Read the notice at the SEC.

equitySEC
May 2021$4 MNo. 6$2 to $10 million

Jet Health, Inc.: Raise no. 6, May 2021

Investors in this round

7 investors had bought by the notice of May 21, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series E-1 Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jim J. Douthitt · Executive Officer · Mr. Douthitt is the Secretary of the Issuer.
  • Stacie J. Bratcher · Executive Officer · Ms. Bratcher is the President and Chief Executive Officer of the Issuer.
  • David Tamburri · Director
  • James Glynn · Director
  • Liston J. Thomas · Director
  • Stephen Griggs · Director
  • Thomas Flynn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacie Bratcher, Chief Executive Officer & President of the Issuer. Newest notice filed May 21, 2021. Read the notice at the SEC.

equitySEC
Apr 2021$5 MNo. 5$2 to $10 million

Jet Health, Inc.: Raise no. 5, Apr 2021

Investors in this round

7 investors had bought by the notice of Apr 16, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series E Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jim J. Douthitt · Executive Officer · Mr. Douthitt is the Secretary of the Issuer.
  • Stacie J. Bratcher · Executive Officer · Ms. Bratcher is the President and Chief Executive Officer of the Issuer.
  • David Tamburri · Director
  • James Glynn · Director
  • Liston J. Thomas · Director
  • Stephen Griggs · Director
  • Thomas Flynn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacie Bratcher, Chief Executive Officer & President of the Issuer. Newest notice filed Apr 16, 2021. Read the notice at the SEC.

equitySEC
Apr 2019$6 MNo. 4$2 to $10 million

Jet Health, Inc.: Raise no. 4, Apr 2019

Investors in this round

7 investors had bought by the notice of May 10, 2019: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alicia J. Price · Executive Officer
  • James D. Glynn · Executive Officer, Director
  • Thomas J. Flynn · Executive Officer, Director
  • David J. Tamburri · Director
  • Liston J. Thomas · Director
  • Stephen J. Griggs · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “SAFE Conversion and Series C Preferred Stock”

Signed by James D. Glynn, CEO and President. Newest notice filed May 10, 2019. Read the notice at the SEC.

equity, debtSEC
Apr 2018$1 MNo. 3Under $2 million

Jet Health, Inc.: Raise no. 3, Apr 2018

Investors in this round

7 investors had bought by the notice of Apr 23, 2018: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James D. Glynn · Executive Officer, Director
  • Matthew J. Crooks · Executive Officer
  • Thomas J. Flynn · Executive Officer, Director
  • David J. Tamburri · Director
  • Liston J. Thomas · Director
  • Stephen J. Griggs · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A-1 Preferred Stock”

Signed by James D. Glynn, CEO and President. Newest notice filed Apr 23, 2018. Read the notice at the SEC.

equitySEC
Jan 2017$4 MNo. 2$2 to $10 million

Jet Health, Inc.: Raise no. 2, Jan 2017

Investors in this round

9 investors had bought by the notice of Jan 19, 2017: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James D. Glynn · Executive Officer, Director
  • Thomas J. Flynn · Executive Officer, Director
  • David J. Tamburri · Director
  • Liston J. Thomas · Director
  • Stephen J. Griggs · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A-1 Preferred Stock and Series B-1 Preferred Stock. Part of the total amount sold includes the value of an exchange of stock.”

Signed by James D. Glynn, CEO and President. Newest notice filed Jan 19, 2017. Read the notice at the SEC.

equitySEC
Apr 2016$17 MNo. 1$10 to $50 million

Jet Health, Inc.: Raise no. 1, Apr 2016

Investors in this round

9 investors had bought by the notice of Apr 26, 2016: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Common Stock, Series A Preferred Stock and Series B Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Glynn · Executive Officer, Director, Promoter · Mr. Glynn is the Chief Executive Officer and President of the Issuer.
  • Thomas Flynn · Executive Officer, Promoter · Mr. Flynn is the Secretary and Treasurer of the Issuer.
  • David Tamburri · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Part of the total amount sold includes the value of an exchange of stock.”

Signed by James Glynn, Chief Executive Officer and President of the Issuer. Newest notice filed Apr 26, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Jet Health, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2022).

    SEC Form D · Jun 2022

  • The industry group it chose in its notices: Other.

    SEC Form D · Jun 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Jet Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Jet Health, Inc.
NameRoleNamed in
James D. GlynnMr. Glynn is the Chairman of the Board of Directors.Jun 2022
James M. DouthittMr. Douthitt is the Chief Financial Officer and Secretary of the Issuer.Jun 2022
Stacie J. BratcherMs. Bratcher is the President and Chief Executive Officer of the Issuer.Jun 2022
Jim J. DouthittMr. Douthitt is the Secretary of the Issuer.May 2021
Alicia J. PriceExecutive officerMay 2019
Thomas J. FlynnExecutive officerMay 2019
Matthew J. CrooksExecutive officerApr 2018
James GlynnMr. Glynn is the Chief Executive Officer and President of the Issuer.Apr 2016
Thomas FlynnMr. Flynn is the Secretary and Treasurer of the Issuer.Apr 2016
David J. TamburriDirectorJun 2022
James D. GlynnMr. Glynn is the Chairman of the Board of Directors.Jun 2022
Jerome John LydenDirectorJun 2022
Liston J. ThomasDirectorJun 2022
Stephen J. GriggsDirectorJun 2022
Thomas J. FlynnDirectorJun 2022
David TamburriDirectorMay 2021
James GlynnDirectorMay 2021
Stephen GriggsDirectorMay 2021
Thomas FlynnDirectorMay 2021
James GlynnMr. Glynn is the Chief Executive Officer and President of the Issuer.Apr 2016
Thomas FlynnMr. Flynn is the Secretary and Treasurer of the Issuer.Apr 2016